Key facts
- This page summarizes Kristin Patrick's Form 4 filing for ChromaDex Corp. (NAGE).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Aug 2024, 19:06.
Kristin Patrick - 23 Aug 2024 Form 4 Insider Report for ChromaDex Corp. (NAGE)
- Reporting relationship
- Director
- Issuer ticker
- NAGE
- Reported as of
- 23 Aug 2024
- Net transaction value
- -$43,790
- SEC form
- 4
- Accepted by SEC
- 26 Aug 2024, 19:06:28 UTC
- Prior SEC filing
- 24 Jun 2024
- Next SEC filing
- 26 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeong James Lee, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kristin Patrick filed Form 4 for ChromaDex Corp. (NAGE) on 26 Aug 2024.
Change
- Previous filing in this sequence was filed on 24 Jun 2024.
- Current net transaction value: -$43,790.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDXC
transaction
Common Stock
Options Exercise
- Transaction value
- $4,920
- Shares
- +3,000
- Change %
- Price
- $1.64
- Shares after
- 3,000
- Date
- 23 Aug 2024
- Ownership
- Direct
CDXC
transaction
Common Stock
Options Exercise
- Transaction value
- $33,400
- Shares
- +20,000
- Change %
- +667%
- Price
- $1.67
- Shares after
- 23,000
- Date
- 23 Aug 2024
- Ownership
- Direct
CDXC
transaction
Common Stock
Sale
- Transaction value
- $82,110
- Shares
- -23,000
- Change %
- -100%
- Price
- $3.57
- Shares after
- 0
- Date
- 23 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDXC
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,000
- Change %
- -15%
- Price
- $0.000000
- Shares after
- 17,000
- Date
- 23 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $1.64
CDXC
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 23 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $1.67
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The weighted average sale price for the transaction reported was $3.57, and the range of prices were between $3.52 and $3.64. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.